[D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake

Peptides

Volumn 21, Issue 3, 2000, Pages 393-399

  Parker, Eric M ^a   Balasubramaniam, Ambikaipakan ^b   Guzzi, Mario ^a   Mullins, Deborra E ^a   Salisbury, Brian G ^a   Sheriff, Sulaiman ^b   Witten, Melanie B ^a   Hwa, Joyce J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

D Trp32 NPY; D Trp34 NPY; Food intake; Neuropeptide Y; Neuropeptide Y receptor; Y5 receptor

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; CGP 71683 A; CYCLIC AMP; D TRP(34) NEUROPEPTIDE Y; D-TRP(34) NEUROPEPTIDE Y; DRUG DERIVATIVE; NAPHTHALENE DERIVATIVE; NEUROPEPTIDE Y5 RECEPTOR; PYRIMIDINE DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APPETITE; ARTICLE; FOOD INTAKE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; ANIMAL; BINDING COMPETITION; CALORIC INTAKE; CELL LINE; CHO CELL; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSFECTION; HAMSTER; KINETICS; LONG EVANS RAT; METABOLISM;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CHO CELLS; CRICETINAE; CYCLIC AMP; ENERGY INTAKE; HUMANS; KINETICS; MALE; NAPHTHALENES; NEUROPEPTIDE Y; PYRIMIDINES; RATS; RATS, LONG-EVANS; RECEPTORS, NEUROPEPTIDE Y; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0033625419     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00156-X     Document Type: Article

References (25)

1. 32]neuropeptide Y. A competitive antagonist of NPY in rat hypothalamus. J Med Chem. 37:1994;811-815.
2. Bischoff A., Avramidis P., Erdbrugger W., Munter K., Michel M.C. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol. 120:1997;1335-1343.
3. Bischoff A., Michel M.C. Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype. Endocrinology. 139:1998;3018-3021.
4. 5 receptor. J Clin Invest. 12:1998;2136-2145.
5. Doods H.N., Wieland H.A., Engel W., Eberlein W., Willim K.D., Entzeroth M., Wienen W., Rudolf K. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist a review of its pharmacological properties . Regul Pept. 65:1996;71-77.
6. Gehlert D.R., Schober D.A., Beavers L., Gadski R., Hoffman J.A., Smiley D.L., Chance R.E., Lundell I., Larhammar D. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol. 50:1996;112-118.
7. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family physiological implications . Proc Soc Exp Biol Med. 218:1998;7-22.
8. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
9. 2 . Endocrinology. 123:1988;2597-2599.
10. Gribkoff V.K., Pieschl R.L., Wisialowski T.A., van den Pol A.N., Yocca F.D. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y mediation by different receptor subtypes . J Neurosci. 18:1998;3014-3022.
11. Hipskind P.A., Lobb K.L., Nixon J.A., Britton T.C., Bruns R.F., Catlow J., Dieckman-McGinty D.K., Gackenheimer S.L., Gitter B.D., Iyengar S., Schober D.A., Simmons R.M., Swanson S., Zarrinmayeh H., Zimmerman D.M., Gehlert D.R. Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists. J Med Chem. 40:1997;3712-3714.
12. Kask A., Rago L., Harro J. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake studies with Y1-selective antagonist BIBP3226 . Br J Pharmacol. 124:1998;1507-1515.
13. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med. 4:1998;718-721.
14. 32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior. Neuropeptides. 30:1996;391-398.
15. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 50:1998;143-150.
16. 4 receptor agonists. Eur J Pharmacol. 349:1998;97-105.
17. Pheng L.H., Quirion R., Iyengar S., Fournier A., Regoli D. The rabbit ileum a sensitive and selective preparation for the neuropeptide Y Y5 receptor . Eur J Pharmacol. 333:1997;R3-R5.
18. Schaffhauser A.O., Stricker-Krongrad A., Brunner L., Cumin F., Gerald C., Whitebread S., Criscione L., Hofbauer K.G. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes. 46:1997;1792-1798.
19. Serradeil-Le Gal C., Valette G., Rouby P.E., Pellet A., Oury-Donat F., Brossard G., Lespy L., Marty E., Neliat G., de Cointet P., Maffrand J.-P., Le Fur G. SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett. 362:1995;192-196.
20. Small C.J., Morgan C.G.A., Meeran K., Heath M.M., Gunn I., Edwards C.M.B., Gardiner J., Taylor G.M., Hurley J.D., Rossi M., Goldstone A.P., O'Shea D., Smith D.M., Ghatei M.A., Bloom S.R. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci USA. 94:1997;11686-11691.
21. Wahlestedt C., Reis D.J. Neuropeptide Y-related peptides and their receptors - are the receptor potential therapeutic drug targets? Annu Rev Pharmacol Toxicol. 32:1993;309-352.
22. Woldbye D.P., Klemp K., Madsen T.M. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J Pharmacol Exp Ther. 284:1998;633-636.
23. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors [see comments]. Nat Med. 3:1997;761-764.
24. Wright J., Bolton G., Creswell M., Downing D., Georgic L., Heffner T., Hodges J., MacKenzie R., Wise L. 8-amino-6-(arylsulphonyl)-5-nitroquinolines novel nonpeptide neuropeptide Y1 receptor antagonists . Bioorganic Med Chem Lett. 6:1996;1809-1814.
25. Zarrinmayeh H., Nunes A.M., Ornstein P.L., Zimmerman D.M., Arnold M.B., Schober D.A., Gackenheimer S.L., Bruns R.F., Hipskind P.A., Britton T.C., Cantrell B.E., Gehlert D.R. Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists. J Med Chem. 41:1998;2709-2719.